COVID-19 Vaccine Responses in PIDD Subjects | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
COVID-19 Vaccine Responses in PIDD Subjects	Bruton-type agammaglobulinemia, COVID-19, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Coronaviridae Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, Primary Antibody Deficiencies, Primary Immunodeficiency Diseases, RNA Virus Infections, common variable immunodeficiency, hereditary disease, immune system disorder, inborn error of immunity, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia	Active, not recruiting	Not stated	2025-06-03		NCT05321407

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Duke University	446
Jeffrey Modell Foundation	1
National Institute of Allergy and Infectious Diseases (NIAID)	402
University of North Carolina, Chapel Hill	249
University of South Florida	110

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Duke University	Durham	United States	45
University of North Carolina, Chapel Hill	Chapel Hill	United States	6
University of South Florida	St. Petersburg	United States	3